SCHEMBL3166127

SCHEMBL3166127

c1cc(CNCCN2CCOCC2)ccc1CNCCN1CCOCC1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2C19 P33261 2/20 0.65
ALDH1A1 P00352 1/20 0.60
DPP7 Q9UHL4 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.57
TNKS2 Q9H2K2 1/20 0.57
POLB P06746 2/20 0.52
BACE1 P56817 1/20 0.50
APP P05067 1/20 0.50
KDM1A O60341 1/20 0.50
LMNA P02545 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3179723 0.93 CYP2C19 (0.76) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL27550438 0.92 CYP2D6 (0.57) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL4244933 0.92 KMT2A (0.60) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL12093346 0.92 POLB (0.60) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL14782117 0.92 CYP2D6 (0.57) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL6205018 0.92 CYP2D6 (0.57) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL39631 0.91 DPP7 (0.73) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
Hydrochloric Acid SCHEMBL7000083 0.90 DPP7 (0.71) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
Hydrochloric Acid SCHEMBL5758788 0.90 DPP7 (0.71) CYP2D6CYP3A4CYP2C19ALDH1A1DPP7
SCHEMBL3175221 0.89 CYP2C19 (0.80) CYP2D6CYP3A4CYP2C19ALDH1A1TNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022769-A1 NOVEL POLYNITROGENATED SYSTEMS AS ANTI-HIV AGENTS INSTITUT QUIMIC DE SARRIA CETS (ES) 2010-01-28 US disclosed
EP-2100890-A1 NOVEL POLYNITROGENATED SYSTEMS AS ANTI-HIV AGENTS Institut Quimic De Sarria Cets (ES) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022769-A1 NOVEL POLYNITROGENATED SYSTEMS AS ANTI-HIV AGENTS MSR1, CCR5, CD4 CYP2D6 310/4885CYP3A4 397/4885CYP2C19 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.